3 ms·
Because the manufacturer recommendations are based on achieving the best outcome for the individual receiving the treatment. But we're in a global pandemic, a
by lisper 6y ago
Because the manufacturer recommendations are based on achieving the best outcome for the individual receiving the treatment. But we're in a global pandemic, a situation the world has not faced in living memory. A different quality metric might be appropriate under these circumstances.
- mns 6y agoSo even though the manufacturers (the companies that developed the vaccines, the scientists, the people running the trials, the ones that know the data and went through a full year of tests) keep on recommending 2 doses and the advice given to the UK government was still to stick to the 2 doses, we're now going the way that "we think we know better and it's better to try something new and untested because it's a pandemic and it might be better to have less efficiency to more people, than full efficiency to less people", even though it's, again, not tested and a shot in the dark?